Market capitalization | $137.76m |
Enterprise Value | $112.20m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 1.30 |
EV/Sales (TTM) EV/Sales | 0.22 |
P/S ratio (TTM) P/S ratio | 0.26 |
P/B ratio (TTM) P/B ratio | 0.45 |
Revenue growth (TTM) Revenue growth | -26.00% |
Revenue (TTM) Revenue | $520.50m |
As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.
7 Analysts have issued a DocGo forecast:
7 Analysts have issued a DocGo forecast:
Mar '25 |
+/-
%
|
||
Revenue | 521 521 |
26%
26%
|
|
Gross Profit | 162 162 |
24%
24%
|
|
EBITDA | 14 14 |
74%
74%
|
EBIT (Operating Income) EBIT | -1.18 -1.18 |
103%
103%
|
Net Profit | -0.64 -0.64 |
103%
103%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
DocGo, Inc. engages in the provision of mobile health services. It operates through the following segments: Transportation Services and Mobile Health Solutions. The Transportation Services segment offers on-demand medical mobility solutions which are marketed under the Ambulnz brand. The Mobile Health Solutions segment includes on-site evaluations, diagnostics, triage, treatment, and medicine administration. The company was founded in 2015 by Stanley Vashovsky and is headquartered in New York, NY.
Head office | United States |
CEO | Bienstock Lee |
Employees | 4,400 |
Founded | 2015 |
Website | www.docgo.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.